---
schema_version: "secwatch.filing_event.v1"
accession: "0000318154-26-000124"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2026-08-04T20:03:16+00:00"
generated_at: "2026-08-04T20:04:07.652320+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amgen Q2 2026 revenue up 10% to $10.1B; GAAP EPS $4.37 (+65%), non-GAAP EPS $6.29 (+4%)

## Summary
- Total revenues $10.1B (+10% YoY); product sales +9% driven by volume growth.
- GAAP EPS $4.37 (+65% from $2.65); non-GAAP EPS $6.29 (+4% from $6.02).
- GAAP operating margin 36.8% (+6.5pp); non-GAAP operating margin 48.4% (-0.5pp).
- Free cash flow $3.5B vs $1.9B in Q2 2025, helped by final repatriation tax payment timing.
- Six key growth drivers +26% YoY, ~70% of product sales; 22 products double-digit growth.

## SEC filing metadata
- accession: 0000318154-26-000124
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2026-08-04T20:03:16+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/0000318154-26-000124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/amgn-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000318154-26-000124
- JSON: https://secwatch.observer/filing/0000318154-26-000124.json
- Plain text: https://secwatch.observer/filing/0000318154-26-000124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.